WHO AIDS epidemic is expected to be completed by 2030 at the latest

World Health Organization: All people with HIV should get antiretroviral drugs
Anyone who has HIV infection should start antiretroviral treatment as soon as possible after diagnosis. That would mean that 37 million people worldwide would need to be treated. The World Health Organization (WHO) said that conditions are relaxed and now all population and age groups have the right to subsidized antiretroviral therapy (ART).

21 million deaths over the next 15 years are expected
The expanded use of antiretroviral treatments is supported by recent findings from clinical trials. Early use of ART helps those living longer and healthier lives. It also reduces the risk of transmitting the virus to its partners. The WHO recommends that people with an increased risk of infection should be offered preventive antiretroviral treatment.

Aids should be contained in 2030. Image: Ezume Images - fotolia

Every HIV infected person has the right to a life-saving treatment. "New conditions and guidelines should ensure that all people with HIV have immediate access to antiretroviral therapies," Michel Sidibe, director of UNAIDS, told Reuters. According to UNAIDS, antiretroviral therapy and prevention could help save many lives ... It is estimated that by 2030, approximately 28 million new people will become infected with the virus. In addition, 21 million infected people could die during this period.

New targets for 2020
The extension of the treatment is considered to be at the heart of a new set of targets for 2020. Its goal is to end the AIDS epidemic by 2030. For this, 90 percent of the world's HIV-infected people need to be educated about the disease. Every affected person must be aware that he is ill. In addition, 90 percent should be in antiretroviral therapy. A comprehensive aid program can facilitate HIV testing. Counseling and support for patients should be improved. Access to condoms and clean injection material must be facilitated. "Doctors Without Borders" welcomed this step. The treatment had to be expanded and improved. However, it warns that implementing these recommendations requires massive support from donors and governments.

Major suppliers of HIV drugs required
To implement the plans, it will be necessary to produce large quantities of vaccines. Only in this way is it possible to provide each affected person with antiretroviral therapy. Major suppliers of HIV medicines include Gilead and ViiV Healthcare, the majority of which are owned by GlaxoSmithKline (GSK). There are still several Indian manufacturers who also produce and sell said drugs. (As)